المؤلفون: Nizamani M; Ruth K. M. Pfau Civil Hospital Karachi, Karachi, Pakistan. Electronic address: misbahnizamani1999@gmail.com., Zaheer Uddin M; Jinnah Sindh Medical University, Karachi, Pakistan., Nagdev C; Chandka Medical College, Larkana, Pakistan., Ahmed N; Jinnah Postgraduate Medical Centre, Karachi, Pakistan., Raza A; Multan Medical and Dental College, Multan, Pakistan.

المصدر: European journal of obstetrics, gynecology, and reproductive biology [Eur J Obstet Gynecol Reprod Biol] 2024 Aug; Vol. 299, pp. 289-295. Date of Electronic Publication: 2024 Jun 27.

نوع المنشور: Comparative Study; Journal Article; Meta-Analysis; Systematic Review

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 0375672 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7654 (Electronic) Linking ISSN: 03012115 NLM ISO Abbreviation: Eur J Obstet Gynecol Reprod Biol Subsets: MEDLINE

مواضيع طبية MeSH: Cabergoline*/therapeutic use , Cabergoline*/administration & dosage , Drug Therapy, Combination* , Hyperprolactinemia*/drug therapy , Hyperprolactinemia*/blood , Metformin*/therapeutic use , Metformin*/administration & dosage , Polycystic Ovary Syndrome*/drug therapy , Polycystic Ovary Syndrome*/complications , Polycystic Ovary Syndrome*/blood , Randomized Controlled Trials as Topic*, Female ; Humans ; Hypoglycemic Agents/therapeutic use ; Hypoglycemic Agents/administration & dosage ; Testosterone/blood

المؤلفون: Pavan Kumar N; ICMR-National Institute for Research in Tuberculosis, Chennai, India. Electronic address: nathella.pk@icmr.gov.in., Padmapriyadarsini C; ICMR-National Institute for Research in Tuberculosis, Chennai, India., Nancy A; ICMR-National Institute for Research in Tuberculosis-International Center for Excellence in Research, Chennai, India., Tamizhselvan M; ICMR-National Institute for Research in Tuberculosis, Chennai, India., Mohan A; All India Institute for Medical Sciences, New Delhi, India., Reddy D; ICMR-National Institute for Research in Tuberculosis, Chennai, India., Ganga Devi NP; ICMR-National Institute for Research in Tuberculosis, Chennai, India., Rathinam P; Government Rajaji Hospital, Madurai, India., Jeyadeepa B; ICMR-National Institute for Research in Tuberculosis, Chennai, India., Shandil RK; Open Source Pharma Foundation, Bangalore, India., Guleria R; All India Institute for Medical Sciences, New Delhi, India., Singh M; Indian Council of Medical Research, New Delhi, India., Babu S; ICMR-National Institute for Research in Tuberculosis-International Center for Excellence in Research, Chennai, India.

المصدر: Tuberculosis (Edinburgh, Scotland) [Tuberculosis (Edinb)] 2024 Sep; Vol. 148, pp. 102523. Date of Electronic Publication: 2024 Jun 01.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Churchill Livingstone Country of Publication: Scotland NLM ID: 100971555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-281X (Electronic) Linking ISSN: 14729792 NLM ISO Abbreviation: Tuberculosis (Edinb) Subsets: MEDLINE

مواضيع طبية MeSH: Metformin*/therapeutic use , Metformin*/pharmacology , Antitubercular Agents*/therapeutic use , Chemokine CXCL10*/blood, Humans ; Female ; Male ; Adult ; Chemokines/blood ; Treatment Outcome ; Young Adult ; Time Factors ; Mycobacterium tuberculosis/drug effects ; Chemokine CCL1/blood ; Chemokine CCL3/blood ; Middle Aged ; Drug Therapy, Combination ; Tuberculosis, Pulmonary/drug therapy ; Tuberculosis, Pulmonary/blood ; Tuberculosis, Pulmonary/immunology ; Bacterial Load/drug effects ; Tuberculosis/drug therapy ; Tuberculosis/blood ; Tuberculosis/immunology

المؤلفون: Heydarnia E; Department of Medical Nanotechnology, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran., Sepasi A; Department of Medical Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.; Department of Genetics, Breast Cancer Research Center, Motamed Cancer Institute, Tehran, Iran., Asefi N; Department of Genetics, Breast Cancer Research Center, Motamed Cancer Institute, Tehran, Iran., Khakshournia S; Department of Clinical Biochemistry, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran., Mohammadnejad J; Department of Life Science Engineering, Faculty of New Science and Technologies, University of Tehran, Tehran, 14395-1561, Iran. mohamadnejad@ut.ac.ir.

المصدر: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 Sep; Vol. 397 (9), pp. 7213-7221. Date of Electronic Publication: 2024 Apr 24.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1912 (Electronic) Linking ISSN: 00281298 NLM ISO Abbreviation: Naunyn Schmiedebergs Arch Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Metformin*/pharmacology , Metformin*/administration & dosage , Sorafenib*/pharmacology , Sorafenib*/administration & dosage , Breast Neoplasms*/drug therapy , Breast Neoplasms*/pathology , Breast Neoplasms*/metabolism , Cell Survival*/drug effects , Nanoparticles* , Cell Proliferation*/drug effects , Apoptosis*/drug effects , Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/administration & dosage, Humans ; MCF-7 Cells ; Female

المؤلفون: Andavar M; Department of Pharmacy Practice, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu 603 203, India., Kamaraj R; Department of Pharmaceutical Regulatory Affairs, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu 603 203, India. Electronic address: kamarajr@srmist.edu.in., Mahalingam Vijayakumar T; Department of Pharmacy Practice, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu 603 203, India., Murugesan A; Department of Obstetrics and Gynaecology, Faculty of Medicine, SRM Medical College Hospital and Research Centre, Kattankulathur, Tamil Nadu 603 203, India.

المصدر: European journal of obstetrics, gynecology, and reproductive biology [Eur J Obstet Gynecol Reprod Biol] 2024 Sep; Vol. 300, pp. 6-11. Date of Electronic Publication: 2024 Jul 03.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 0375672 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7654 (Electronic) Linking ISSN: 03012115 NLM ISO Abbreviation: Eur J Obstet Gynecol Reprod Biol Subsets: MEDLINE

مواضيع طبية MeSH: Polycystic Ovary Syndrome*/drug therapy , Polycystic Ovary Syndrome*/complications , Metformin*/therapeutic use , Metformin*/administration & dosage , Inositol*/administration & dosage , Inositol*/therapeutic use , Acarbose*/therapeutic use , Acarbose*/administration & dosage , Drug Therapy, Combination* , Hypoglycemic Agents*/therapeutic use , Hypoglycemic Agents*/administration & dosage, Humans ; Female ; Adult ; Young Adult ; Insulin Resistance ; Follicle Stimulating Hormone/blood ; Luteinizing Hormone/blood ; Treatment Outcome

المؤلفون: Abbasi M; Department of Nutritional Sciences, College of Human Sciences, Auburn University, Auburn, Alabama, USA., Heath B; Department of Biomedical Sciences, College of Sciences and Mathematics, Auburn University, Auburn, Alabama, USA., McGinness L; Department of Nutritional Sciences, College of Human Sciences, Auburn University, Auburn, Alabama, USA.

المصدر: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Sep; Vol. 26 (9), pp. 3513-3529. Date of Electronic Publication: 2024 Jul 10.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE

مواضيع طبية MeSH: Metformin*/therapeutic use , Metformin*/administration & dosage , Drug Delivery Systems* , Hypoglycemic Agents*/administration & dosage , Hypoglycemic Agents*/therapeutic use , Diabetes Mellitus, Type 2*/drug therapy , Obesity*/drug therapy, Humans ; Obesity Management/methods ; Biological Availability

المؤلفون: Han KA; Division of Endocrinology and Metabolism, Nowon Eulji Medical Centre, Eulji University, Seoul, South Korea., Hwang YC; Division of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, Seoul, South Korea., Moon SJ; Division of Endocrinology and Metabolism, Hallym University Kangnam Sacred Heart Hospital, Seoul, South Korea., Cho HC; Division of Endocrinology and Metabolism, Keimyung University Dongsan Hospital, Daegu, South Korea., Yoo HJ; Division of Endocrinology and Metabolism, Korea University College of Medicine, Seoul, South Korea., Choi SH; Division of Endocrinology and Metabolism, Seoul National University Bundang Hospital, Seongnam, South Korea., Chon S; Division of Endocrinology and Metabolism, Kyung Hee University Hospital, Seoul, South Korea., Kim KA; Division of Endocrinology and Metabolism, Dongguk University Ilsan Hospital, Dongguk University School of Medicine, Goyang, South Korea., Kim TN; Division of Endocrinology and Metabolism, Inje University Haeundae Paik Hospital, Busan, South Korea., Kang JG; Division of Endocrinology and Metabolism, Hallym University Sacred Heart Hospital, Seoul, South Korea., Park CY; Division of Endocrinology and Metabolism, Kangbuk Samsung Hospital, Seoul, South Korea., Won JC; Division of Endocrinology and Metabolism, Inje University Sanggye Paik Hospital, Seoul, South Korea., Cho E; Life Sciences, LG Chem, Ltd, Seoul, South Korea., Kim J; Life Sciences, LG Chem, Ltd, Seoul, South Korea., Park KS; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.

المصدر: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Sep; Vol. 26 (9), pp. 3743-3752. Date of Electronic Publication: 2024 Jul 08.

نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/blood , Glucosides*/therapeutic use , Glucosides*/administration & dosage , Glucosides*/adverse effects , Metformin*/therapeutic use , Metformin*/administration & dosage , Benzhydryl Compounds*/therapeutic use , Drug Therapy, Combination* , Glycated Hemoglobin*/analysis , Glycated Hemoglobin*/drug effects , Hypoglycemic Agents*/therapeutic use , Hypoglycemic Agents*/administration & dosage , Hypoglycemic Agents*/adverse effects , Piperidones*/therapeutic use , Piperidones*/administration & dosage , Piperidones*/adverse effects , Pyrimidines*/therapeutic use , Pyrimidines*/administration & dosage , Pyrimidines*/adverse effects, Humans ; Female ; Male ; Middle Aged ; Double-Blind Method ; Aged ; Blood Glucose/drug effects ; Blood Glucose/analysis ; Blood Glucose/metabolism ; Glycemic Control/methods ; Adult ; Treatment Outcome ; Hypoglycemia/chemically induced ; Hypoglycemia/epidemiology ; Hypoglycemia/prevention & control ; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use

المؤلفون: Park JY; Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea., Lee J; Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea., Choi YH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.; MedicalExcellence Inc., Seoul, Korea., Min KW; Division of Endocrinology and Metabolism, Department of Internal Medicine, Eulji General Hospital, Eulji University School of Medicine, Seoul, Korea., Han KA; Division of Endocrinology and Metabolism, Department of Internal Medicine, Eulji General Hospital, Eulji University School of Medicine, Seoul, Korea., Ahn KJ; Division of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul, Korea., Lim S; Division of Endocrinology and Metabolism, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea., Kim YH; Division of Endocrinology and Metabolism, Bundang Jesaeng Hospital, Seongnam, Korea., Ahn CW; Division of Endocrinology and Metabolism, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea., Choi KM; Department of Endocrinology, Korea University Guro Hospital, Seoul, Korea., Yoon KH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.; Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Korea.

المصدر: Diabetes & metabolism journal [Diabetes Metab J] 2024 Sep; Vol. 48 (5), pp. 915-928. Date of Electronic Publication: 2024 Apr 23.

نوع المنشور: Journal Article; Randomized Controlled Trial; Multicenter Study

بيانات الدورية: Publisher: Korean Diabetes Association Country of Publication: Korea (South) NLM ID: 101556588 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2233-6087 (Electronic) Linking ISSN: 22336079 NLM ISO Abbreviation: Diabetes Metab J Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/drug therapy , Uracil*/analogs & derivatives , Uracil*/therapeutic use , Uracil*/adverse effects , Uracil*/administration & dosage , Pioglitazone*/therapeutic use , Pioglitazone*/administration & dosage , Piperidines*/therapeutic use , Piperidines*/adverse effects , Piperidines*/administration & dosage , Metformin*/therapeutic use , Metformin*/administration & dosage , Metformin*/adverse effects , Hypoglycemic Agents*/therapeutic use , Hypoglycemic Agents*/administration & dosage , Hypoglycemic Agents*/adverse effects , Glycated Hemoglobin*/analysis , Drug Therapy, Combination* , Blood Glucose*/drug effects , Blood Glucose*/analysis, Humans ; Male ; Female ; Double-Blind Method ; Middle Aged ; Aged ; Treatment Outcome ; Republic of Korea ; Adult

المؤلفون: Danduga RCSR; Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's NMIMS, V.L. Mehta Road, Vile Parle (W), Mumbai, 400056, India. ravichandra.pharma2262@gmail.com., Kurapati AS; Department of Pharmacology, Acharya Nagarjuna University College of Pharmaceutical Sciences, Acharya Nagarjuna University, Guntur, 522510, India., Shaik RA; Department of Pharmacology, Acharya Nagarjuna University College of Pharmaceutical Sciences, Acharya Nagarjuna University, Guntur, 522510, India., Kola PK; Department of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND, 58203, USA., Konidala SK; Department of Pharmaceutical Sciences, School of Biotechnology and Pharmaceutical Sciences, Vignan's Foundation for Sciences, Technology, and Research, Vadlamudi, Guntur, 522213, India., Varada HB; Department of Pharmacology, Acharya Nagarjuna University College of Pharmaceutical Sciences, Acharya Nagarjuna University, Guntur, 522510, India.

المصدر: Reproductive sciences (Thousand Oaks, Calif.) [Reprod Sci] 2024 Sep; Vol. 31 (9), pp. 2861-2876. Date of Electronic Publication: 2024 May 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 101291249 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1933-7205 (Electronic) Linking ISSN: 19337191 NLM ISO Abbreviation: Reprod Sci Subsets: MEDLINE

مواضيع طبية MeSH: Polycystic Ovary Syndrome*/chemically induced , Polycystic Ovary Syndrome*/drug therapy , Polycystic Ovary Syndrome*/pathology , Letrozole*/administration & dosage , Metformin*/pharmacology , Metformin*/administration & dosage , Rats, Wistar* , Acetic Acid* , Oxidative Stress*/drug effects , Hypoglycemic Agents*/pharmacology , Hypoglycemic Agents*/administration & dosage , Drug Synergism* , Drug Therapy, Combination*, Animals ; Female ; Rats ; Ovary/drug effects ; Ovary/pathology ; Ovary/metabolism ; Malus/chemistry ; Blood Glucose/drug effects ; Blood Glucose/metabolism ; Aromatase Inhibitors/pharmacology ; Aromatase Inhibitors/administration & dosage ; Estrous Cycle/drug effects

المؤلفون: Naem AAA; Najaf Health Department, Alhakeem General Hospital, Najaf, Iraq., Al-Terehi MN; College of Science, University of Babylon, Babylon, Iraq., Ghafil FA; Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Kufa, Kufa, Iraq., Ataya FS; Department of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia., Batiha GE; Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour, Egypt., Alexiou A; University Centre for Research & Development, Chandigarh University, Mohali, India.; Department of Science and Engineering, Novel Global Community Educational Foundation, Hebersham, New South Wales, Australia.; Department of Research & Development, Funogen, Athens, Greece.; Department of Research & Development, AFNP Med, Wien, Austria., Papadakis M; Department of Surgery II, University Hospital Witten-Herdecke, University of Witten-Herdecke, Wuppertal, Germany., Welson NN; Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Beni-Suef University, Beni Suef, Egypt., Hadi NR; Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Kufa, Kufa, Iraq.

المصدر: Endocrinology, diabetes & metabolism [Endocrinol Diabetes Metab] 2024 Sep; Vol. 7 (5), pp. e486.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons Ltd Country of Publication: England NLM ID: 101732442 Publication Model: Print Cited Medium: Internet ISSN: 2398-9238 (Electronic) Linking ISSN: 23989238 NLM ISO Abbreviation: Endocrinol Diabetes Metab Subsets: MEDLINE

مواضيع طبية MeSH: Metformin*/administration & dosage , Metformin*/therapeutic use , Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/genetics , Organic Cation Transport Proteins*/genetics , Hypoglycemic Agents*/administration & dosage , Hypoglycemic Agents*/therapeutic use , Polymorphism, Single Nucleotide*, Humans ; Male ; Female ; Middle Aged ; Cross-Sectional Studies ; Adult ; Aged ; Genotype ; Blood Glucose

المؤلفون: Ríos JA; Facultad de Medicina y Ciencia, Escuela de Medicina, Universidad San Sebastián, Santiago, Chile., Bórquez JC; Centro de Excelencia en Biomedicina de Magallanes (CEBIMA), Escuela de Medicina, Universidad de Magallanes, Punta Arenas, Chile; Facultad de Ciencias de la Salud, Universidad de Magallanes, Punta Arenas, Chile., Godoy JA; Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile., Zolezzi JM; Centro de Excelencia en Biomedicina de Magallanes (CEBIMA), Escuela de Medicina, Universidad de Magallanes, Punta Arenas, Chile., Furrianca MC; Facultad de Ciencias de la Salud, Universidad de Magallanes, Punta Arenas, Chile., Inestrosa NC; Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile; Centro de Excelencia en Biomedicina de Magallanes (CEBIMA), Escuela de Medicina, Universidad de Magallanes, Punta Arenas, Chile. Electronic address: ninestrosa@bio.puc.cl.

المصدر: Ageing research reviews [Ageing Res Rev] 2024 Sep; Vol. 100, pp. 102439. Date of Electronic Publication: 2024 Jul 27.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Science Country of Publication: England NLM ID: 101128963 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-9649 (Electronic) Linking ISSN: 15681637 NLM ISO Abbreviation: Ageing Res Rev Subsets: MEDLINE

مواضيع طبية MeSH: Alzheimer Disease*/drug therapy , Alzheimer Disease*/metabolism , Metformin*/therapeutic use , Metformin*/pharmacology , Hypoglycemic Agents*/therapeutic use , Hypoglycemic Agents*/pharmacology , Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/metabolism, Humans ; Animals ; Translational Research, Biomedical/methods ; Neuroprotective Agents/therapeutic use ; Neuroprotective Agents/pharmacology ; Insulin Resistance/physiology